Influences on community pharmacists' recommendation of non-prescription H2-antagonists

Pharmaceutical Journal

Volumn 256, Issue 6876, 1996, Pages 593-596

  McCafferty, Sarah L ^a   Rogers, Philip J ^a   Wood, Sandra M ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NON PRESCRIPTION DRUG;

ARTICLE; ATTITUDE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; HEARTBURN; PHARMACIST; PRESCRIPTION; QUESTIONNAIRE; SYMPTOM;

EID: 0029958994     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Pharmacists do not supervise P sales well enough, says Which? Pharm J 1994;252:767.
2. Pharmacists ask "too many questions." Ibid. 1994;252:897.
3. Clark ML, Kumar PJ, editors Clinical medicine. 3rd ed. Glasgow: Balliere Tyndall, 1994.
4. Blenkinsopp A, Paxton P Symptoms in the pharmacy. 2nd ed Oxford: Blackwell Scientific Publications, 1995.
5. Li Wan Po A. ENCORE A structured approach to responding to symptoms. Pharm J 1992;248.158-61.
6. Adair CG, Mawhinney WM Gastrointestinal disease - The upper gastrointestinal tract. Belfast: Northern Ireland Centre for Postgraduate Pharmaceutical Education and Training, 1994.
7. Stockley I. Drug interactions (3rd ed.). Oxford: Blackwell Scientific Publications. 1994.
8. Bond CM. Guidelines for dyspepsia treatment. Pharm J 1994;252:228-9
9. Siegel S, Castellan NJ. Nonparametric statistics for the behavioural sciences. 2nd ed New York-McGraw Hill, 1988
10. 2 blockers "small impact so far". Pharm J 1995;254:846.
11. Zantac 75 goes top. Ibid 1995;255:147.